myirislogo
24 October, 2019 02:38 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Infosys 650.75 1.16
Tata Motors 132.65 0.57
Tata Power 60.80 2.62
Adani Ports 396.25 5.85
State Bank O 275.50 1.87
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Marksans Pharma Limited
Marksans Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524404NSE:MARKSANSBloomberg:MRKS@INReuters:MARK.BO
Market Lot: 1Face Value: 1ISIN Demat: INE750C01026
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
10-MAY-17 Marksans Pharma's Goa plant has been approved by UK Medicines and Healthcare products Regulatory Agency (UK MHRA). The UK's healthcare regulator inspected the company's Goa plant from February 14, 2017 to February 17, 2017. 10-APR-17 Marksans Pharma manufacturing facility at Verna, Goa has been audited by the United States Food and Drug Administration (USFDA) from April 3 to 7, 2017. 18-OCT-16 Marksans Pharma announced that USFDA ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Marksans Pharma gets 4 USFDA observations for Goa facility  -IRIS 10-Apr-17
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2016(12)31-Mar-2015 (12)31-Mar-2014 (12)
Net sales 3645.204055.943149.45
Other Income0.000.000.00
Total Income3645.204055.943149.45
Cost of goods sold2586.282898.532311.28
OPBDIT1058.921157.41838.17
PAT714.86671.09555.58
Gross Block---
Equity capital409.31409.31385.31
EPS (Rs.)-1.641.44
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-12.26 - 43.902.50 - 18.33
Debt / Equity (x)---
Operating margin (% of OI)29.028.526.6
Net margin (% of OI)19.616.517.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
11th Floor, Lotus Business Park
Off New Link Road
Andheri (West)
Mumbai
Maharashtra-400 053
PHONE
(022) 4001 2000
FAX
(022) 4001 2011
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer